Arvada, CO, United States of America

Doug Johnson

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Nacuity Pharmaceuticals, Inc., Nacuity Pharmaceutials, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doug Johnson. Retrieved from https://idiyas.com/inventor/doug-johnson-yiq0peim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Doug Johnson

Introduction

Doug Johnson is an accomplished inventor based in Arvada, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of N-acetyl cysteine amide and its derivatives. With a total of 3 patents, his work showcases his dedication to advancing medical science.

Latest Patents

Doug Johnson's latest patents focus on innovative methods for the preparation of N-acetyl cysteine amide. The first patent outlines a process that includes contacting cystine with an alcohol and a chlorinating reagent to create an organic solution containing L-cystine dimethylester dihydrochloride. The subsequent steps involve combining this compound with triethylamine, acetic anhydride, and acetonitrile to form a di-N-acetylcystine dimethylester. Finally, the process culminates in mixing the dried di-N-acetylcystine dimethylester with ammonium hydroxide to produce di-N-acetylcystine amide, which is then separated into N-acetylcysteine amide using dithiothreitol, triethylamine, and an alcohol.

Career Highlights

Throughout his career, Doug has worked with notable companies such as Nacuity Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop and refine his innovative methods, contributing to advancements in drug preparation and formulation.

Collaborations

Doug Johnson has collaborated with talented individuals in his field, including G Michael Wall and Anja Rubenstein. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Doug Johnson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the industry positively, paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…